The ultrastructural difference between CD133-positive U251 glioma stem cells and normal U251 glioma cells

Ultrastructural Pathology

Volumn 36, Issue 6, 2012, Pages 404-408

  Yang, Bo ^a   Wang, You ^a   Yang, Chunxu ^a   Ouyang, Wen ^a   Zhou, Fuxiang ^a   Zhou, Yunfeng ^a   Xie, Conghua ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cell nucleus; Endoplasmic reticulum; Glioma; Microvillus; Stem cell; Ultrastructure

Indexed keywords

CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ARTICLE; CANCER STEM CELL; CELL NUCLEUS; COMPARATIVE STUDY; ENDOPLASMIC RETICULUM; FLUORESCENCE MICROSCOPY; GLIOMA; HUMAN; IMMUNOLOGY; METABOLISM; MICROVILLUS; PHENOTYPE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTIGENS, CD; CELL LINE, TUMOR; CELL NUCLEUS; ENDOPLASMIC RETICULUM; GLIOMA; GLYCOPROTEINS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MICROVILLI; NEOPLASTIC STEM CELLS; PEPTIDES; PHENOTYPE;

EID: 84870811604     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2012.708011     Document Type: Article

References (31)

1. Binello E, Germano IM. Targeting glioma stem cells: a novel framework for brain tumors. Cancer Sci. 2011; 102:1958-1966.
2. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004; 64:7011-7021.
3. Singh SK, Clarke ID, Terasaki M, et al. Identifcation of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63:5821-5828.
4. Singh SK, Hawkins C, Clarke ID, et al. Identifcation of human brain tumour initiating cells. Nature. 2004; 432:396-401.
5. Yuan X, Curtin J, Xiong Y, et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene. 2004; 23:9392-9400.
6. Tirino V, Desiderio V, d'Aquino R, et al. Detection and characterization of CD133+ cancer stem cells in human solid tumours. PloS One. 2008; 3:e3469.
7. Zhang M, Song T, Yang L, et al. Nestin and CD133: valuable stem cell-specifc markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res: CR. 2008; 27:85.
8. Altaner C. Glioblastoma and stem cells. Neoplasma; 2008; 55:369-374.
9. Jin F, Gao C, Zhao L, et al. Using CD133 positive U251 glio-blastoma stem cells to establish nude mice model of transplanted tumor. Brain Res. 2011; 1368:82-90.
10. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med. 2011; 17:313-319.
11. Heddleston JM, Wu Q, Rivera M, et al. Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumori-genic potential. Cell Death Differ. 2012; 19:428-439.
12. Eyler CE, Wu Q, Yan K, et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell. 2011; 146:53-66.
13. Wang J, Wang C, Meng Q, et al. siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth. Mol Biol Rep. 2012; 39:2497-2503.
14. Zheng H, Ying H, Yan H, et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature. 2008; 455:1129-1133.
15. Clement V, Sanchez P, de Tribolet N, et al. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol: CB. 2007; 17:165-172.
16. Hiroshima K, Shibuya K, Shimamura F, et al. Pulmonary large cell carcinoma with rhabdoid phenotype. Ultrastruct Pathol. 2003; 27:55-59.
17. Nakashima Y, Yao T, Hirahashi M, et al. Nuclear atypia grading score is a useful prognostic factor in papillary gastric adenocarcinoma. Histopathology. 2011; 59:841-849.
18. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444:756-760.
19. Arum CJ, Anderssen E, Viset T, et al. Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer. Neoplasia .2010; 12:434-442.
20. Zaguia F, Schneider R. Microvilli expressed on glioma cells keep cytotoxic cells at a distance. Cancer Biol Ther. 2011; 11:1-3.
21. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to pheno-typically diverse progeny and survive chemotherapy. Breast Cancer Res. 2008; 10:R25.
22. Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007; 104:10158-10163.
23. Li C, Heidt DG, Dalerba P, et al. Identifcation of pancreatic cancer stem cells. Cancer Res. 2007; 67:1030-1037.
24. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identifcation and expansion of human colon-cancer-initiating cells. Nature. 2007; 445:111-115.
25. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identifcation of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100:3983-3988.
26. Chen YC, Chen YW, Hsu HS, et al. Aldehyde dehydroge-nase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun. 2009; 385:307-313.
27. Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res. 2009; 7:330-338.
28. Seigel GM, Campbell LM, Narayan M, et al. Cancer stem cell characteristics in retinoblastoma. Mol Vis. 2005; 11:729-737.
29. Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydroge-nase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009; 69:3382-3389.
30. Croker AK, Goodale D, Chu J, et al. High aldehyde dehydro-genase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastati-cability. J Cell Mol Med. 2009; 13: 2236-2252.
31. Morimoto K, Kim SJ, Tanei T, et al. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci. 2009; 100:1062-1068.